1. Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase. Burgess SC, Hausler N, Merritt M, Jeffrey FM, Storey C, Milde A, Koshy S, Lindner J, Magnuson MA, Malloy CR, Sherry AD (2004) J Biol Chem 279(47): 48941-9
    › Primary publication · 15347677 (PubMed)
  2. Efficient DNA cassette exchange in mouse embryonic stem cells by staggered positive-negative selection. Long Q, Shelton KD, Lindner J, Jones JR, Magnuson MA (2004) Genesis 39(4): 256-62
    › Primary publication · 15286998 (PubMed)
  3. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren PO, Magnuson MA (2002) J Biol Chem 277(40): 37176-83
    › Primary publication · 12149271 (PubMed)
  4. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA (1999) J Biol Chem 274(1): 305-15
    › Primary publication · 9867845 (PubMed)
  5. Targeted oncogenesis of hormone-negative pancreatic islet progenitor cells. Jetton TL, Moates JM, Lindner J, Wright CV, Magnuson MA (1998) Proc Natl Acad Sci U S A 95(15): 8654-9
    › Primary publication · 9671733 (PubMed) · PMC21131 (PubMed Central)
  6. Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: evaluation of spatial and temporal information imparted by 3 kb of 5' regulatory sequence for the alpha 2A AR-receptor gene in transgenic animals. Wang R, Macmillan LB, Fremeau RT, Magnuson MA, Lindner J, Limbird LE (1996) Neuroscience 74(1): 199-218
    › Primary publication · 8843087 (PubMed)
  7. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM (1991) J Clin Endocrinol Metab 73(6): 1360-9
    › Primary publication · 1955518 (PubMed)
  8. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men. Lindner J, Rivier JE, Vale WW, Pavlou SN (1990) J Clin Endocrinol Metab 70(4): 1219-24
    › Primary publication · 1690747 (PubMed)
  9. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ (1990) J Clin Endocrinol Metab 70(5): 1472-8
    › Primary publication · 2110578 (PubMed)
  10. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M (1989) J Clin Endocrinol Metab 68(2): 446-54
    › Primary publication · 2537334 (PubMed)